Neurorestorative therapy for stroke

Frontiers in Human Neuroscience

Volumn 8, Issue JUNE, 2014, Pages

  Chen, Jieli ^a   Venkat, Poornima ^a,b   Zacharek, Alex ^a   Chopp, Michael ^a,b  

^a HENRY FORD HOSPITAL   (United States)

^b OAKLAND UNIVERSITY   (United States)

Author keywords

BMSC; HUCBC; MicroRNA; Neurorestoration; Niaspan

Indexed keywords

ANGIOTENSIN I; ANTINEOPLASTIC AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; FIBROBLAST GROWTH FACTOR 2; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MICRORNA; MICRORNA 146B; MICRORNA 33B; NERVE GROWTH FACTOR; NICOTINIC ACID; PLACENTAL GROWTH FACTOR; SCATTER FACTOR; SIMVASTATIN; SOMATOMEDIN; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANTIANGIOGENIC THERAPY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BRAIN ISCHEMIA; CD34 SELECTION; CELL BASED GENE THERAPY; CELL COMMUNICATION; CELL PROLIFERATION; CELL THERAPY; CENTRAL NERVOUS SYSTEM; CYTOKINE PRODUCTION; GENE TRANSFER; GLIOBLASTOMA; GROWTH REGULATION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOMODULATION; LOW DRUG DOSE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOLECULAR MECHANICS; NERVE CELL DIFFERENTIATION; NERVE CELL LESION; NERVE CELL PLASTICITY; NERVE FIBER; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NEUROLOGIC DISEASE; NEUROPROTECTION; NEURORESTORATIVE THERAPY; OLIGODENDROGENESIS; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); REVIEW; SPINAL CORD INJURY; SUBGRANULAR ZONE; SUBVENTRICULAR ZONE; SYNAPTOGENESIS; UMBILICAL CORD BLOOD; WHITE MATTER;

EID: 84903475709     PISSN: None     EISSN: 16625161     Source Type: Journal    
DOI: 10.3389/fnhum.2014.00382     Document Type: Review

References (175)

1. Allen, C. M. (1984). Predicting the outcome of acute stroke: a prognostic score. J. Neurol. Neurosurg. Psychiatry 47, 475-480. doi:10.1136/jnnp.47.5.475
2. Almici, C., Carlo-Stella, C., Wagner, J. E., and Rizzoli, V.(1995). Umbilical cord blood as a source of hematopoietic stem cells: from research to clinical application. Haematologica 80, 473-479.
3. Andrews, E. M., Tsai, S. Y., Johnson, S. C., Farrer, J. R., Wagner, J. P., Kopen, G. C., et al. (2008). Human adult bone marrow-derived somatic cell therapy results in functional recovery and axonal plasticity following stroke in the rat. Exp. Neurol. 211, 588-592. doi:10.1016/j.expneurol.2008.02.027
4. Arenillas, J. F., Sobrino, T., Castillo, J., and Davalos,A. (2007). The role of angiogene-sis in damage and recovery from ischemic stroke. Curr. Treat. Options Cardiovasc. Med. 9, 205-212. doi:10.1007/s11936-007-0014-5
5. Arien-Zakay, H., Lecht, S., Nagler, A., and Lazarovici, P. (2011). Neuroprotection by human umbilical cord blood-derived progenitors in ischemic brain injuries. Arch. Ital. Biol. 149, 233-245. doi:10.4449/aib.v149i2.1370
6. Back, S. A., Han, B. H., Luo, N. L., Chricton, C. A., Xanthoudakis, S., Tam, J., et al. (2002). Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J. Neurosci. 22, 455-463.
7. Bang, O. Y., Lee, J. S., Lee, P. H., and Lee, G. (2005). Autologous mesenchy-mal stem cell transplantation in stroke patients. Ann. Neurol. 57, 874-882. doi:10.1002/ana.20501
8. Bao, X., Wei, J., Feng, M., Lu, S., Li, G., Dou, W., et al. (2011). Transplantation of human bone marrow-derived mesenchymal stem cells promotes behavioral recovery and endogenous neurogenesis after cerebral ischemia in rats. Brain Res. 7, 103-113. doi:10.1016/j.brainres.2010.10.063
9. Berezovskaya, O., Maysinger, D., and Fedoroff, S. (1995). The hematopoietic cytokine, colony-stimulating factor 1, is also a growth factor in the CNS: congenital absence of CSF-1 in mice results in abnormal microglial response and increased neuron vulnerability to injury. Int. J. Dev. Neurosci. 13, 285-299. doi:10.1016/0736-5748(95)00013-7
10. Bianco, P., and Gehron Robey, P. (2000). Marrow stromal stem cells. J. Clin. Invest. 105, 1663-1668. doi:10.1172/JCI10413
11. Buschmann, I., and Schaper, W. (1999). Arteriogenesis versus angiogenesis: two mechanisms of vessel growth. News Physiol. Sci. 14, 121-125.
12. Buschmann, I., and Schaper, W. (2000). The pathophysiology of the collateral circulation (arteriogenesis). J. Pathol. 190, 338-342. doi:10.1002/(SICI)1096-9896(200002)190:3<338::AID-PATH594>3.0.CO,2-7
13. Cairns, K., and Finklestein, S. P. (2003). Growth factors and stem cells as treatments for stroke recovery. Phys. Med. Rehabil. Clin. N. Am. 14, S135-S142. doi:10.1016/S1047-9651(02)00059-1
14. Carmeliet, P. (2000). Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6, 389-395. doi:10.1038/80430
15. Carmichael, S. T. (2003). Plasticity of cortical projections after stroke. Neuroscientist. 9, 64-75. doi:10.1177/1073858402239592
16. Carmichael, S. T., Wei, L., Rovainen, C. M., and Woolsey, T. A. (2001). New patterns of intracortical projections after focal cortical stroke. Neurobiol. Dis. 8, 910-922. doi:10.1006/nbdi.2001.0425
17. Carpenter, C. R., Keim, S. M., Milne, W. K., Meurer, W. J., and Barsan, W. G. (2011). Thrombolytic therapy for acute ischemic stroke beyond three hours. J. Emerg. Med. 40, 82-92. doi:10.1016/j.jemermed.2010.05.009
18. Chang, E. H., Rigotti, A., and Huerta, P. T. (2009). Age-related influence of the HDL receptor SR-BI on synaptic plasticity and cognition. Neurobiol. Aging 30, 407-419. doi:10.1016/j.neurobiolaging.2007.07.006
19. Chang, S. J., Weng, S. L., Hsieh, J. Y., Wang, T. Y., Chang, M. D., and Wang, H. W. (2011). MicroRNA-34a modulates genes involved in cellular motility and oxida-tive phosphorylation in neural precursors derived from human umbilical cord mesenchymalstemcells.BMC Med. Genomics 4:65. doi:10.1186/1755-8794-4-65
20. Chen, C. T., Foo, N. H., Liu, W. S., and Chen, S. H. (2008). Infusion of human umbilical cord blood cells ameliorates hind limb dysfunction in experimental spinal cord injury through anti-inflammatory, vasculogenic and neurotrophic mechanisms. Pediatr. Neonatol. 49, 77-83. doi:10.1016/S1875-9572(08)60017-0
21. Chen, J., and Chopp, M. (2006). Neurorestorative treatment of stroke: cell and pharmacological approaches. NeuroRx 3, 466-473. doi:10.1016/j.nurx.2006. 07.007
22. Chen, J., Cui, X., Zacharek, A., Cui, Y., Roberts, C., and Chopp, M. (2011). White matter damage and the effect of matrix metalloproteinases in type 2 diabetic mice after stroke. Stroke 42, 445-452. doi:10.1161/STROKEAHA.110.596486
23. Chen, J., Cui, X., Zacharek, A., Ding,G. L., Shehadah, A., Jiang, Q.,et al. (2009). Nias-pan treatment increases tumor necrosis factor-alpha-converting enzyme and promotes arteriogenesis after stroke. J. Cereb. Blood Flow Metab. 29, 911-920. doi:10.1038/jcbfm.2009.11
24. Chen, J., Cui, X., Zacharek, A., Jiang, H., Roberts, C., Zhang, C., et al. (2007). Nias-pan increases angiogenesis and improves functional recovery after stroke. Ann. Neurol. 62, 49-58. doi:10.1002/ana.21160
25. Chen, J., Li, Y., Katakowski, M., Chen, X., Wang, L., Lu, D.,et al. (2003a). Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J. Neurosci. Res. 73, 778-786. doi:10.1002/jnr.10691
26. Chen, J., Li, Y., Wang, L., Zhang, Z., Lu, D., Lu, M., et al. (2001a). Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32, 1005-1011. doi:10.1161/01.STR.32.4.1005
27. Chen, J., Sanberg, P. R., Li, Y., Wang, L., Lu, M., Willing, A. E., et al. (2001b). Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 32, 2682-2688. doi:10.1161/hs1101.098367
28. Chen, J., Zacharek, A., Cui, X., Shehadah, A., Jiang, H., Roberts, C., et al. (2010). Treatment of stroke with a synthetic liver X receptor agonist, TO901317, promotes synaptic plasticity and axonal regeneration in mice. J. Cereb. Blood Flow Metab. 30, 102-109. doi:10.1038/jcbfm.2009.187
29. Chen, J., Zacharek, A., Li, Y., Li, A., Wang, L., Katakowski, M., et al. (2006). N-cadherin mediates nitric oxide-induced neurogenesis in young and retired breeder neurospheres. Neuroscience 140, 377-388. doi:10.1016/j.neuroscience. 2006.02.064
30. Chen, J., Zhang, Z. G., Li, Y., Wang, L., Xu, Y. X., Gautam, S. C., et al. (2003b). Intravenous administration of human bone marrow stromal cells induces angiogen-esis in the ischemic boundary zone after stroke in rats. Circ. Res. 92, 692-699. doi:10.1161/01.RES.0000063425.51108.8D
31. Chen, J. J., and Zhou, S. H. (2011). Mesenchymal stem cells overexpressing MiR-126 enhance ischemic angiogenesis via the AKT/ERK-related pathway. Cardiol. J. 18, 675-681. doi:10.5603/CJ.2011.0032
32. Chen, S. H., Wang, J. J., Chen, C. H., Chang, H. K., Lin, M. T., Chang, F. M., et al. (2013). Umbilical cord blood-derived CD34+ cells improve outcomes of traumatic brain injury in rats by stimulating angiogenesis and neurogenesis. Cell Transplant. 12, 12.
33. Chen, X., Katakowski, M., Li, Y., Lu, D., Wang, L., Zhang, L., et al. (2002a). Human bone marrow stromal cell cultures conditionedbytraumatic brain tissue extracts: growth factor production. J. Neurosci. Res. 69, 687-691. doi:10.1002/jnr.10334
34. Chen, X., Li, Y., Wang, L., Katakowski, M., Zhang, L., Chen, J., et al. (2002b). Ischemic rat brain extracts induce human marrow stromal cell growth factor production. Neuropathology 22, 275-279. doi:10.1046/j.1440-1789.2002.00450.x
35. Chopp, M., Li, Y., and Zhang, Z. G. (2009). Mechanisms underlying improved recovery of neurological function after stroke in the rodent after treatment with neurorestorative cell-based therapies. Stroke 40, S143-S145. doi:10.1161/ STROKEAHA.108.533141
36. Christoforidis, G. A., Mohammad, Y., Kehagias, D., Avutu, B., and Slivka, A. P. (2005). Angiographic assessment of pial collaterals as a prognostic indicator following intra-arterial thrombolysis for acute ischemic stroke. AJNR Am. J. Neuroradiol. 26, 1789-1797.
37. Collino, F., Bruno, S., Deregibus, M. C., Tetta, C., and Camussi, G. (2011). "Chapter fourteen-microRNAs and mesenchymal stem cells," in Vitamins & Hormones, ed. L. Gerald (Academic Press), 291-320.
38. Cramer, S. C., and Chopp, M. (2000). Recovery recapitulates ontogeny. Trends Neu-rosci. 23, 265-271. doi:10.1016/S0166-2236(00)01562-9
39. Cronin, C. A. (2010). Intravenous tissue plasminogen activator for stroke: a review of the ECASS III results in relation to prior clinical trials. J. Emerg. Med. 38, 99-105. doi:10.1016/j.jemermed.2009.08.004
40. Cui, X., Chopp, M., Zacharek, A., Roberts, C., Buller, B., Ion, M., et al. (2010). Niacin treatment of stroke increases synaptic plasticity and axon growth in rats. Stroke 41, 2044-2049. doi:10.1161/STROKEAHA.110.589333
41. Cui, X., Chopp, M., Zacharek, A., Roberts, C., Lu, M., Savant-Bhonsale, S., et al. (2009). Chemokine, vascular and therapeutic effects of combination Simvas-tatin and BMSC treatment of stroke. Neurobiol. Dis. 36, 35-41. doi:10.1016/j. nbd.2009.06.012
42. Dancause, N., Barbay, S., Frost, S. B., Plautz, E. J., Chen, D., Zoubina, E. V., et al. (2005). Extensive cortical rewiring after brain injury. J. Neurosci. 25, 10167-10179. doi:10.1523/JNEUROSCI.3256-05.2005
43. Ding, J., Cheng, Y., Gao, S., and Chen, J. (2011). Effects of nerve growth factor and Noggin-modified bone marrow stromal cells on stroke in rats. J. Neurosci. Res. 89, 222-230. doi:10.1002/jnr.22535
44. Dor, Y., and Keshet, E. (1997). Ischemia-driven angiogenesis. Trends Cardiovasc. Med. 7, 289-294. doi:10.1016/S1050-1738(97)00091-1
45. Erdo, F., and Buschmann, I. R. (2007). Arteriogenesis: a new strategy of therapeutic intervention in chronic arterial disorders. Cellular mechanism and experimental models. Orv. Hetil. 148, 633-642.
46. Feng, Y., Wang, Y., Pfister, F., Hillebrands, J. L., Deutsch, U., and Hammes, H. P. (2009). Decreased hypoxia-induced neovascularization in angiopoietin-2 heterozygous knockout mouse through reduced MMP activity. Cell. Physiol. Biochem. 23, 277-284. doi:10.1159/000218174
47. Folkman, J., and D'Amore, P.A.(1996). Bloodvessel formation:what isits molecular basis? Cell 87, 1153-1155.
48. Friedenstein, A. J., Chailakhyan, R. K., and Gerasimov, U. V. (1987). Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet. 20, 263-272.
49. Friedenstein, A. J., Petrakova, K. V., Kurolesova, A. I., and Frolova, G. P. (1968). Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6, 230-247. doi:10.1097/00007890-196803000-00009
50. Gensert, J. M., and Goldman, J. E. (1997). Endogenous progenitors remyelinate demyelinated axons in the adult CNS. Neuron 19, 197-203. doi:10.1016/S0896-6273(00)80359-1
51. Granger, C. V., Hamilton, B. B., and Fiedler, R. C. (1992). Discharge outcome after stroke rehabilitation. Stroke 23, 978-982.
52. Greenberg, D. A. (1998). Angiogenesis and stroke. Drug News Perspect. 11, 265-270. doi:10.1358/dnp.1998.11.5.657287
53. Grotta, J. C., Jacobs, T. P., Koroshetz, W. J., and Moskowitz, M. A. (2008). Stroke program review group: an interim report. Stroke 39, 1364-1370. doi:10.1161/ STROKEAHA.107.510776
54. Gutierrez-Fernandez, M., Rodriguez-Frutos, B., Ramos-Cejudo, J., Teresa Vallejo-Cremades, M., Fuentes, B., Cerdan, S.,et al. (2013). Effects of intravenous administration of allogenic bone marrow and adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke. Stem Cell Res Ther. 4, 11. doi:10.1186/scrt159
55. Hardy, S. A., Maltman, D. J., and Przyborski, S. A. (2008). Mesenchymal stem cells as mediators of neural differentiation. Curr. Stem Cell Res. Ther. 3, 43-52. doi:10.2174/157488808783489471
56. Henning, R. J., Abu-Ali, H., Balis, J. U., Morgan, M. B., Willing, A. E., and Sanberg, P. R. (2004). Human umbilical cord blood mononuclear cells for the treatment of acute myocardial infarction. Cell Transplant. 13, 729-739. doi:10.3727/000000004783983477
57. Hermann, D. M., and Chopp, M. (2012). Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation. Lancet Neurol. 11, 369-380. doi:10.1016/S1474-4422(12)70039-X
58. Hoefer, I. E., van Royen, N., Rectenwald, J. E., Bray, E. J., Abouhamze, Z., Moldawer, L. L., et al. (2002). Direct evidence for tumor necrosis factor-alpha signaling in arteriogenesis. Circulation 105, 1639-1641. doi:10.1161/01.CIR.0000014987. 32865.8E
59. Hou, S. T., Jiang, S. X., and Smith, R. A. (2008). Permissive and repulsive cues and signalling pathways of axonal outgrowth and regeneration. Int. Rev. Cell Mol. Biol. 267, 125-181. doi:10.1016/S1937-6448(08)00603-5
60. Hu, C. H., Wu, G. F., Wang, X. Q., Yang, Y. H., Du, Z. M., He, X. H., et al. (2006). Transplanted human umbilical cord blood mononuclear cells improve left ventricular function through angiogenesis in myocardial infarction. Chin. Med. J. 119, 1499-1506.
61. Huang, F., Zhu, X., Hu, X. Q., Fang, Z. F., Tang, L., Lu, X. L., et al. (2013a). Mesenchy-mal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival. Int. J. Mol. Med. 31, 484-492. doi:10.3892/ijmm.2012.1200
62. Huang, W., Mo, X., Qin, C., Zheng, J., Liang, Z., and Zhang, C. (2013b). Transplantation of differentiated bone marrow stromal cells promotes motor functional recovery in rats with stroke. Neurol. Res. 35, 320-328. doi:10.1179/1743132812Y. 0000000151
63. Hurtado, O., Pradillo, J. M., Alonso-Escolano, D., Lorenzo, P., Sobrino, T., Castillo, J., et al. (2006). Neurorepair versus neuroprotection in stroke. Cerebrovasc. Dis. 21(Suppl. 2), 54-63. doi:10.1159/000091704
64. Iwai, M., Stetler, R. A., Xing, J., Hu, X., Gao, Y., Zhang, W., et al. (2010). Enhanced oligodendrogenesis and recovery of neurological function by erythropoietin after neonatal hypoxic/ischemic brain injury. Stroke 41, 1032-1037. doi:10.1161/ STROKEAHA.109.570325
65. Jiang, Y., Zhu, W., Zhu, J., Wu, L., Xu, G., and Liu, X. (2012). Feasibility of delivering mesenchymal stem cells via catheter to the proximal end of lesion artery in patients with stroke in the territory of middle cerebral artery. Cell Transplant. 1, 1. doi:10.3727/096368912X658818
66. Jin, F.-Y., Kamanna, V. S., and Kashyap, M. L. (1997). Niacin decreases removal of high-density lipoprotein apolipoprotein A-I but not cholesterol ester by Hep G2 cells: implication for reverse cholesterol transport. Arterioscler. Thromb. Vasc. Biol. 17, 2020-2028. doi:10.1161/01.ATV.17.10.2020
67. Juranek, J. K., Geddis, M. S., Song, F., Zhang, J., Garcia, J., Rosario, R., et al. (2013). RAGE deficiency improves postinjury sciatic nerve regeneration in type 1 diabetic mice. Diabetes 62, 931-943. doi:10.2337/db12-0632
68. Kamanna, V. S., and Kashyap, M. L. (2008). Mechanism of action of niacin. Am. J. Cardiol. 101, 029. doi:10.1016/j.amjcard.2008.02.029
69. Karasinska, J. M., Rinninger, F., Lutjohann, D., Ruddle, P., Franciosi, S., Kruit, J. K., et al. (2009). Specific loss of brain ABCA1 increases brain cholesterol uptake and influences neuronal structure and function. J. Neurosci. 29, 3579-3589. doi:10.1523/JNEUROSCI.4741-08.2009
70. Katakowski, M., Buller, B., Zheng, X., Lu, Y., Rogers, T., Osobamiro, O., et al. (2013).Exosomesfrom marrowstromalcellsexpressingmiR-146b inhibitglioma growth. Cancer Lett. 335, 201-204. doi:10.1016/j.canlet.2013.02.019
71. Katsuda, T., Kosaka, N., Takeshita, F., and Ochiya, T. (2013). The therapeutic potential of mesenchymal stem cell-derived extracellular vesicles. Proteomics 13, 1637-1653. doi:10.1002/pmic.201200373
72. Katzan, I. L., Hammer, M. D., Hixson, E. D., Furlan, A. J., Abou-Chebl, A., and Nadzam, D. M. (2004). Utilization of intravenous tissue plasminogen activator for acute ischemic stroke. Arch. Neurol. 61, 346-350. doi:10.1001/archneur. 61.3.346
73. Kinnaird, T., Stabile, E., Burnett, M. S., Lee, C. W., Barr, S., Fuchs, S., et al. (2004). Marrow-derived stromal cells express genes encoding a broad spectrum of arte-riogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ. Res. 94, 678-685. doi:10.1161/01.RES.0000118601. 37875.AC
74. Kobayashi, T., Ahlenius, H., Thored, P., Kobayashi, R., Kokaia, Z., and Lindvall, O. (2006). Intracerebral infusion of glial cell line-derived neurotrophic factor promotes striatal neurogenesis after stroke in adult rats. Stroke 37, 2361-2367. doi:10.1161/01.STR.0000236025.44089.e1
75. Kozlowska, H., Jablonka, J., Janowski, M., Jurga, M., Kossut, M., and Domanska-Janik, K. (2007). Transplantation of a novel human cord blood-derived neural-like stem cell line in a rat model of cortical infarct. Stem Cells Dev. 16, 481-488. doi:10.1089/scd.2007.9993
76. Krupinski, J., Kaluza, J., Kumar, P., Kumar, S., and Wang, J. M. (1994). Role of angiogenesis in patients with cerebral ischemic stroke. Stroke 25, 1794-1798. doi:10.1161/01.STR.25.9.1794
77. Laine, S. K., Alm, J. J., Virtanen, S. P., Aro, H. T., and Laitala-Leinonen, T. K. (2012). MicroRNAs miR-96, miR-124, and miR-199a regulate gene expression in human bone marrow-derived mesenchymal stem cells. J. Cell. Biochem. 113, 2687-2695. doi:10.1002/jcb.24144
78. Landers, M. (2004). Treatment-induced neuroplasticity following focal injury to the motor cortex. Int. J. Rehabil. Res. 27, 1-5. doi:10.1097/00004356-200403000-00001
79. Lee, J. S., Hong, J. M., Moon, G. J., Lee, P. H., Ahn, Y. H., and Bang, O. Y. (2010). A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells 28, 1099-1106. doi:10.1002/stem.430
80. Leonardo, C. C., Hall, A. A., Collier, L. A., Ajmo, C. T. Jr., Willing, A. E., and Pen-nypacker, K. R. (2010). Human umbilical cord blood cell therapy blocks the morphological change and recruitment of CD11b-expressing, isolectin-binding proinflammatory cells after middle cerebral artery occlusion. J. Neurosci. Res. 88, 1213-1222. doi:10.1002/jnr.22306
81. Li, Y., Chen, J., Chen, X. G., Wang, L., Gautam, S. C., Xu, Y. X., et al. (2002). Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 59, 514-523. doi:10.1212/WNL.59.4.514
82. Li, Y., Chen, J., and Chopp, M. (2001a). Adult bone marrow transplantation after stroke in adult rats. Cell Transplant. 10, 31-40.
83. Li, Y., Chen, J., Wang, L., Lu, M., and Chopp, M. (2001b). Treatment of stroke in rat with intracarotid administration of marrow stromal cells. Neurology 56, 1666-1672. doi:10.1212/WNL.56.12.1666
84. Liebeskind, D. S. (2005). Neuroprotection from the collateral perspective. Idrugs 8, 222-228.
85. Lim, P. K., Patel, S. A., Gregory, L. A., and Rameshwar, P. (2010). Neurogenesis: role for microRNAs and mesenchymal stem cells in pathological states. Curr. Med. Chem. 17, 2159-2167. doi:10.2174/092986710791299894
86. Liu, N., Deguchi, K., Yamashita, T., Liu, W., Ikeda, Y., and Abe, K. (2012). Intracere-bral transplantation of bone marrow stromal cells ameliorates tissue plasmino-gen activator-induced brain damage after cerebral ischemia in mice detected by in vivo and ex vivo optical imaging. J. Neurosci. Res. 90, 2086-2093. doi:10.1002/jnr.23104
87. Liu, X., Ye, R., Yan, T., Yu, S. P., Wei, L., Xu, G., et al. (2014). Cell based therapies for ischemic stroke: from basic science to bedside. Prog. Neurobiol. 115, 92-115. doi:10.1016/j.pneurobio.2013.11.007
88. Liu, Z., Li, Y., Zhang, Z. G., Cui, X., Cui, Y., Lu, M., et al. (2010). Bone marrow stromal cells enhance inter and intra-cortical axonal connections after ischemic stroke in adult rats. J. Cereb. Blood Flow Metab. 30, 1288-1295. doi:10.1038/ jcbfm.2010.8
89. Liu, Z., Zhang, R. L., Li, Y., Cui, Y., and Chopp, M. (2009). Remodeling of the corticospinal innervation and spontaneous behavioral recovery after ischemic stroke in adult mice. Stroke 40, 2546-2551. doi:10.1161/STROKEAHA.109. 547265
90. Lu, D., Sanberg, P. R., Mahmood, A., Li, Y., Wang, L., Sanchez-Ramos, J., et al. (2002). Intravenous administrationofhuman umbilical cord bloodreduces neurological deficit in the rat after traumatic brain injury. Cell Transplant. 11, 275-281.
91. Lutsenko, S. V., Kiselev, S. M., and Severin, S. E. (2003). Molecular mechanisms of tumor angiogenesis. Biochemistry Mosc. 68, 286-300.
92. Madri, J. A. (2009). Modeling the neurovascular niche: implications for recovery from CNS injury. J. Physiol. Pharmacol. 4, 95-104.
93. Malgieri, A., Kantzari, E., Patrizi, M. P., and Gambardella, S. (2010). Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art. Int. J. Clin. Exp. Med. 3, 248-269.
94. Matsuda-Hashii, Y., Takai, K., Ohta, H., Fujisaki, H., Tokimasa, S., Osugi, Y., et al. (2004). Hepatocyte growth factor plays roles in the induction and autocrine maintenance of bone marrow stromal cell IL-11, SDF-1 alpha, and stem cell factor. Exp. Hematol. 32, 955-961.
95. Matsui, M., and Tabata, Y. (2012). Enhanced angiogenesis by multiple release of platelet-rich plasma contents and basic fibroblast growth factor from gelatin hydrogels. Acta Biomater. 8, 1792-1801. doi:10.1016/j.actbio.2012.01.016
96. McTigue, D. M., and Tripathi, R. B. (2008). The life, death, and replacement of oligo-dendrocytes in the adult CNS. J. Neurochem. 107, 1-19. doi:10.1111/j.1471-4159. 2008.05570.x
97. Mehler, M. F., Rozental, R., Dougherty, M., Spray, D. C., and Kessler, J. A. (1993). Cytokine regulation of neuronal differentiation of hippocampal progenitor cells. Nature 362, 62-65. doi:10.1038/362062a0
98. Miller, A. M., Gilchrist, D. S., Nijjar, J., Araldi, E., Ramirez, C. M., Lavery, C. A., et al. (2013). MiR-155 has a protective role in the development of non-alcoholic hepatosteatosisin mice. PLoS ONE 8:e72324. doi:10.1371/journal.pone.0072324
99. Modo, M., Rezaie, P., Heuschling, P., Patel, S., Male, D. K., and Hodges, H. (2002a). Transplantation of neural stem cells in a rat model of stroke: assessment of short-term graft survival and acute host immunological response. Brain Res. 958, 70-82. doi:10.1016/S0006-8993(02)03463-7
100. Modo, M., Stroemer, R. P., Tang, E., Patel, S., and Hodges, H. (2002b). Effects of implantation site of stem cell grafts on behavioral recovery from stroke damage. Stroke 33, 2270-2278. doi:10.1161/01.STR.0000027693.50675.C5
101. Moniche, F., Gonzalez, A., Gonzalez-Marcos, J. R., Carmona, M., Pinero, P., Espigado, I., et al. (2012). Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial. Stroke 43, 2242-2244. doi:10.1161/STROKEAHA. 112.659409
102. Morgado, J. M., Pratas, R., Laranjeira, P., Henriques, A., Crespo, I., Regateiro, F., et al. (2008). The phenotypical and functional characteristicsof cord blood monocytes and CD14(-/low)/CD16(+) dendritic cells can be relevant to the development of cellular immune responses after transplantation. Transpl. Immunol. 19, 55-63. doi:10.1016/j.trim.2007.11.002
103. Munoz, J. R., Stoutenger, B. R., Robinson, A. P., Spees, J. L., and Prockop, D. J. (2005). Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc. Natl. Acad. Sci. U.S.A. 102, 18171-18176. doi:10.1073/pnas.0508945102
104. Nakahata, T., and Ogawa, M. (1982). Hemopoietic colony-forming cells in umbilical cord blood with extensive capability to generate mono and multi-potential hemopoietic progenitors. J. Clin. Invest. 70, 1324-1328. doi:10.1172/JCI110734
105. Navarro-Sobrino, M., Rosell, A., Hernandez-Guillamon, M., Penalba, A., Boada, C., Domingues-Montanari, S., et al. (2011). A large screening of angiogenesis bio-markers and their association with neurological outcome after ischemic stroke. Atherosclerosis 216, 205-211. doi:10.1016/j.atherosclerosis.2011.01.030
106. Neuhoff, S., Moers, J., Rieks, M., Grunwald, T., Jensen, A., Dermietzel, R., et al. (2007). Proliferation, differentiation, and cytokine secretion of human umbilical cord blood-derived mononuclear cells in vitro. Exp. Hematol. 35, 1119-1131. doi:10.1016/j.exphem.2007.03.019
107. Newcomb, J. D., Ajmo, C. T. Jr., Sanberg, C. D., Sanberg, P. R., Pennypacker, K. R., and Willing, A. E. (2006). Timing of cord blood treatment after experimental stroke determines therapeutic efficacy. Cell Transplant. 15, 213-223. doi:10.3727/000000006783982043
108. Nikolic, I., Plate, K. H., and Schmidt, M. H. (2010). EGFL7 meets miRNA-126: an angiogenesis alliance. J. Angiogenes. Res. 2, 9. doi:10.1186/2040-2384-2-9
109. Nikolic, W. V., Hou, H., Town, T., Zhu, Y., Giunta, B., Sanberg, C. D., et al. (2008). Peripherally administered human umbilical cord blood cells reduce parenchy-mal and vascular beta-amyloid deposits in Alzheimer mice. Stem Cells Dev. 17, 423-439. doi:10.1089/scd.2008.0018
110. NINDS. (2012). Final Report of the Stroke Progress Review Group-January 2012.
111. Nystedt, J., Makinen, S., Laine, J., and Jolkkonen, J. (2006). Human cord blood CD34+ cells and behavioral recovery following focal cerebral ischemia in rats. Acta Neurobiol. Exp. 66, 293-300.
112. Ohab, J. J., Fleming, S., Blesch, A., and Carmichael, S. T. (2006). A neurovascular niche for neurogenesis after stroke. J. Neurosci. 26, 13007-13016. doi:10.1523/ JNEUROSCI.4323-06.2006
113. Parent, J. M., Vexler, Z. S., Gong, C., Derugin, N., and Ferriero, D. M. (2002). Rat forebrain neurogenesis and striatal neuron replacement after focal stroke. Ann. Neurol. 52, 802-813. doi:10.1002/ana.10393
114. Patan, S. (2004). Vasculogenesis and angiogenesis. Cancer Treat. Res. 117, 3-32.
115. Plate, K. H. (1999). Mechanisms of angiogenesis in the brain. J. Neuropathol. Exp. Neurol. 58, 313-320. doi:10.1097/00005072-199904000-00001
116. Pratt, P. F., Medhora, M., and Harder, D. R. (2004). Mechanisms regulating cerebral blood flow as therapeutic targets. Curr. Opin. Investig. Drugs 5, 952-956.
117. Renner, O., Tsimpas, A., Kostin, S., Valable, S., Petit, E., Schaper, W., et al. (2003). Time and cell type-specific induction of platelet-derived growth factor receptor-beta during cerebral ischemia. Brain Res. Mol. Brain Res. 113, 44-51.
118. Riess, P., Zhang, C., Saatman, K. E., Laurer, H. L., Longhi, L. G., Raghupathi, R., et al. (2002). Transplanted neural stem cells survive, differentiate, and improve neurological motor function after experimental traumatic brain injury. Neurosurgery 51, 1043-1052. doi:10.1097/00006123-200210000-00035
119. Risau, W. (1997). Mechanisms of angiogenesis. Nature 386, 671-674. doi:10.1038/ 386671a0
120. Rowe, D. D., Leonardo, C. C., Hall, A. A., Shahaduzzaman, M. D., Collier, L. A., Willing, A. E., et al. (2010). Cord blood administration induces oligodendro-cyte survival through alterations in gene expression. Brain Res. 17, 172-188. doi:10.1016/j.brainres.2010.09.078
121. Rowe, D. D., Leonardo, C. C., Recio, J. A., Collier, L. A., Willing, A. E., and Pen-nypacker, K. R. (2012). Human umbilical cord blood cells protect oligodendro-cytes from brain ischemia through Akt signal transduction. J. Biol. Chem. 287, 4177-4187. doi:10.1074/jbc.M111.296434
122. Savitz, S. L., Malhotra, S., Gupta, G., and Rosenbaum, D. M. (2003). Cell transplants offer promise for stroke recovery. J. Cardiovasc. Nurs. 18, 57-61. doi:10.1097/ 00005082-200301000-00009
123. Schaper, W., and Buschmann, I. (1999). Arteriogenesis, the good and bad of it. Eur. Heart J. 20, 1297-1299. doi:10.1053/euhj.1999.1686
124. Scholz, D., Cai, W. J., and Schaper, W. (2001). Arteriogenesis, a new concept of vascular adaptation in occlusive disease. Angiogenesis 4, 247-257. doi:10.1023/A: 1016094004084
125. Schwammenthal, Y., Tsabari, R., Bakon, M., Orion, D., Merzeliak, O., and Tanne, D. (2006). Thrombolysis in acute stroke. Isr. Med. Assoc. J. 8, 784-787.
126. Seetharam, D., Mineo, C., Gormley, A. K., Gibson, L. L., Vongpatanasin, W., Cham-bliss, K. L., et al. (2006). High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I. Circ. Res. 98, 63-72. doi:10.1161/01.RES.0000199272.59432.5b
127. Sen, C. K. (2011). MicroRNAs as new maestro conducting the expanding symphony orchestra of regenerative and reparative medicine. Physiol. Genomics 43, 517-520. doi:10.1152/physiolgenomics.00037.2011
128. Shehadah, A., Chen, J., Cui, X., Roberts, C., Lu, M., and Chopp, M. (2010a). Combination treatment of experimental stroke with Niaspan and Simvastatin, reduces axonal damage and improves functional outcome. J. Neurol. Sci. 294, 107-111. doi:10.1016/j.jns.2010.03.020
129. Shehadah, A., Chen, J., Cui, Y., Zhang, L., Roberts, C., Lu, M., et al. (2011). Combination treatment with low-dose Niaspan and tissue plasminogen activator provides neuroprotection after embolic stroke in rats. J. Neurol. Sci. 309, 96-101. doi:10.1016/j.jns.2011.07.008
130. Shehadah, A., Chen, J., Zacharek, A., Cui,Y., Ion, M., Roberts, C., et al. (2010b). Nias-pan treatment induces neuroprotection after stroke. Neurobiol. Dis. 40, 277-283. doi:10.1016/j.nbd.2010.05.034
131. Shen, L. H., Li, Y., Chen, J., Zacharek, A., Gao, Q., Kapke, A., et al. (2007). Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke. J. Cereb. Blood Flow Metab. 27, 6-13. doi:10.1038/sj.jcbfm.9600311
132. Shen, L. H., Li, Y., Chen, J., Zhang, J., Vanguri, P., Borneman, J., et al. (2006). Intracarotid transplantation of bone marrow stromal cells increases axon-myelin remodeling after stroke. Neuroscience 137, 393-399. doi:10.1016/j.neuroscience. 2005.08.092
133. Shichinohe, H., Kuroda, S., Maruichi, K., Osanai, T., Sugiyama, T., Chiba, Y., et al. (2010). Bone marrow stromal cells and bone marrow-derived mononuclear cells: which are suitable as cell source of transplantation for mice infarct brain? Neu-ropathology 30, 113-122. doi:10.1111/j.1440-1789.2009.01050.x
134. Skihar, V., Silva, C., Chojnacki, A., Doring, A., Stallcup, W. B., Weiss, S., et al. (2009). Promoting oligodendrogenesis and myelin repair using the multiple sclerosis medication glatiramer acetate. Proc. Natl. Acad. Sci. U.S.A. 106, 17992-17997. doi:10.1073/pnas.0909607106
135. Stroemer, R. P., Kent, T. A., and Hulsebosch, C. E. (1995). Neocortical neural sprouting, synaptogenesis, and behavioral recovery after neocortical infarction in rats. Stroke 26, 2135-2144. doi:10.1161/01.STR.26.11.2135
136. Suarez-Monteagudo, C., Hernandez-Ramirez, P., Alvarez-Gonzalez, L., Garcia-Maeso, I., de la Cuetara-Bernal, K., Castillo-Diaz, L., et al. (2009). Autologous bone marrow stem cell neurotransplantation in stroke patients. An open study. Restor. Neurol. Neurosci. 27, 151-161. doi:10.3233/RNN-2009-0483
137. Suen, Y., Chang, M., Lee, S. M., Buzby, J. S., and Cairo, M. S. (1994). Regulation of interleukin-11 protein and mRNA expression in neonatal and adult fibroblasts and endothelial cells. Blood 84, 4125-4134.
138. Sykova, E., Jendelova, P., Urdzikova, L., Lesny, P., and Hejcl,A. (2006). Bone marrow stem cells and polymer hydrogels-two strategies for spinal cord injury repair. Cell. Mol. Neurobiol. 26, 1113-1129. doi:10.1007/s10571-006-9007-2
139. Taguchi, A., Soma, T., Tanaka, H., Kanda, T., Nishimura, H., Yoshikawa, H., et al. (2004). Administration of CD34+ cells after stroke enhances neuro-genesis via angiogenesis in a mouse model. J. Clin. Invest. 114, 330-338. doi:10.1172/JCI200420622
140. Takahashi, S., Ooi, J., Tomonari, A., Konuma, T., Tsukada, N., Oiwa-Monna, M., et al. (2007). Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen. Blood 109, 1322-1330.
141. Tanaka, K., Nogawa, S., Ito, D., Suzuki, S., Dembo, T., Kosakai, A., et al. (2001). Activation of NG2-positive oligodendrocyte progenitor cells during post-ischemic reperfusion in the rat brain. Neuroreport 12, 2169-2174. doi:10.1097/00001756-200107200-00025
142. Tohill, M., Mantovani, C., Wiberg, M., and Terenghi, G. (2004). Rat bone marrow mesenchymal stem cells express glial markers and stimulate nerve regeneration. Neurosci. Lett. 362, 200-203. doi:10.1016/j.neulet.2004.03.077
143. Ujike, H., Takaki, M., Kodama, M., and Kuroda, S. (2002). Gene expression related to synaptogenesis, neuritogenesis, and MAP kinase in behavioral sensitization to psychostimulants. Ann. N. Y. Acad. Sci. 965, 55-67. doi:10.1111/j.1749-6632. 2002.tb04151.x
144. van Royen, N., Piek, J. J., Buschmann, I., Hoefer, I., Voskuil, M., and Schaper, W. (2001). Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease. Cardiovasc. Res. 49, 543-553. doi:10.1016/S0008-6363(00) 00206-6
145. Vendrame, M., Cassady, J., Newcomb, J., Butler, T., Pennypacker, K. R., Zigova, T., et al. (2004). Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke 35, 2390-2395. doi:10.1161/01.STR.0000141681.06735.9b
146. Vendrame, M., Gemma, C., de Mesquita, D., Collier, L., Bickford, P. C., Sanberg, C. D., et al. (2005). Anti-inflammatory effects of human cord blood cells in a rat model of stroke. Stem Cells Dev. 14, 595-604. doi:10.1089/scd.2005.14.595
147. Vendrame, M., Gemma, C., Pennypacker, K. R., Bickford, P. C., Davis Sanberg, C., Sanberg, P. R., et al. (2006). Cord blood rescues stroke-induced changes in splenocyte phenotype and function. Exp. Neurol. 199, 191-200. doi:10.1016/j. expneurol.2006.03.017
148. Wakabayashi, K., Nagai, A., Sheikh, A. M., Shiota, Y., Narantuya, D., Watanabe, T., et al. (2010). Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model. J. Neurosci. Res. 88, 1017-1025.
149. Walmsley, A. R., and Mir, A. K. (2007). Targeting the Nogo-A signalling pathway to promote recovery following acute CNS injury. Curr. Pharm. Des. 13, 2470-2484. doi:10.2174/138161207781368611
150. Wang, L., Zhang, Z., Wang, Y., Zhang, R., and Chopp, M. (2004). Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 35, 1732-1737. doi:10.1161/01. STR.0000132196.49028.a4
151. Wang, X. Q., Zhu, X. J., and Zou, P. (2013). Research progress of mesenchymal stem cell-derived microvesicle. Zhongguo Shi Yan Xue Ye Xue Za Zhi 21,227-230. doi:10.7534/j.issn.1009-2137.2013.01.046
152. Watson, D. J., Longhi, L., Lee, E. B., Fulp, C. T., Fujimoto, S., Royo, N. C., et al. (2003). Genetically modified NT2N human neuronal cells mediate long-term gene expression as CNS grafts in vivo and improve functional cognitive outcome following experimental traumatic brain injury. J. Neuropathol. Exp. Neurol. 62, 368-380.
153. Wei, L., Erinjeri, J. P., Rovainen, C. M., and Woolsey, T. A. (2001). Collateral growth and angiogenesis around cortical stroke. Stroke 32, 2179-2184. doi:10.1161/hs0901.094282
154. Weimar, C., Kraywinkel, K., Maschke, M., and Diener, H. C. (2006). Intravenous thrombolysis in German stroke units before and after regulatory approval of recombinant tissue plasminogen activator. Cerebrovasc. Dis. 22, 429-431. doi:10.1159/000094995
155. Wen, Z., Zheng, S., Zhou, C., Yuan, W., Wang, J., and Wang, T. (2012). Bone marrow mesenchymal stem cells for post-myocardial infarction cardiac repair: microR-NAs as novel regulators. J. Cell. Mol. Med. 16, 657-671. doi:10.1111/j.1582-4934. 2011.01471.x
156. Weng, J. S., Liu, N., Du, H. W., Chen, R. H., Zhang, Y. X., Wang, J. H., et al. (2008). Effects of bone marrow-derived mesenchymal stem cells transplantation on recovery of neurological functions and expression of synaptophysin in focal cerebral infarction in rats. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 24, 34-37.
157. Willing, A. E., Lixian, J., Milliken, M., Poulos, S., Zigova, T., Song, S., et al. (2003). Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. J. Neurosci. Res. 73, 296-307. doi:10.1002/jnr.10659
158. Xin, H., Li, Y., Cui, Y., Yang, J. J., Zhang, Z. G., and Chopp, M. (2013). Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J. Cereb. Blood Flow Metab. 33, 1711-1715. doi:10.1038/jcbfm.2013.152
159. Xu, J., Wu, W., Zhang, L., Dorset-Martin, W., Morris, M. W., Mitchell, M. E., et al. (2012). The role of microRNA-146a in the pathogenesis of the diabetic wound-healing impairment: correction with mesenchymal stem cell treatment. Diabetes 61, 2906-2912. doi:10.2337/db12-0145
160. Yan, T., Chopp, M., Ye, X., Liu, Z., Zacharek, A., Cui, Y., et al. (2012). Niaspan increases axonal remodeling after stroke in type 1 diabetes rats. Neurobiol. Dis.46,157-164. doi:10.1016/j.nbd.2012.01.001
161. Yasuhara, T., Hara, K., Maki, M., Xu, L., Yu, G., Ali, M. M., et al. (2010). Mannitol facilitates neurotrophic factor up-regulation and behavioural recovery in neonatal hypoxic-ischaemic rats with human umbilical cord blood grafts. J. Cell. Mol. Med. 14, 914-921. doi:10.1111/j.1582-4934.2008.00671.x
162. Yoo, K.H., Jang, I. K., Lee, M.W., Kim, H. E., Yang, M.S., Eom, Y., et al. (2009). Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Cell. Immunol. 259, 150-156. doi:10.1016/j.cellimm. 2009.06.010
163. Yuan, M., Wen, S. J., Yang, C. X., Pang, Y. G., Gao, X. Q., Liu, X. Q., et al. (2013). Transplantation of neural stem cells overexpressing glial cell line-derived neu-rotrophic factor enhances Akt and Erk1/2 signaling and neurogenesis in rats after stroke. Chin. Med. J. 126, 1302-1309.
164. Zacharek, A., Chen, J., Cui, X., Li, A., Li, Y., Roberts, C., et al. (2007). Angiopoi-etin1/Tie2 and VEGF/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke. J. Cereb. Blood Flow Metab. 27, 1684-1691. doi:10.1038/sj.jcbfm.9600475
165. Zhang, J., Li, Y., Zhang, Z. G., Lu, M., Borneman, J., Buller, B., et al. (2009). Bone marrow stromal cells increase oligodendrogenesis after stroke. J. Cereb. Blood Flow Metab. 29, 1166-1174. doi:10.1038/jcbfm.2009.41
166. Zhang, J. H., Badaut, J., Tang, J., Obenaus, A., Hartman, R., and Pearce, W. J. (2012a). The vascular neural network-a new paradigm in stroke pathophysiology. Nat. Rev. Neurol. 8, 711-716. doi:10.1038/nrneurol.2012.210
167. Zhang, L., Li, Y., Zhang, C., Chopp, M., Gosiewska, A., and Hong, K. (2011). Delayed administration of human umbilical tissue-derived cells improved neurological functional recovery in a rodent model of focal ischemia. Stroke 42, 1437-1444. doi:10.1161/STROKEAHA.110.593129
168. Zhang, L., Yi, L., Chopp, M., Kramer, B. C., Romanko, M., Gosiewska, A., et al. (2012b). Intravenous administration of human umbilical tissue-derived cells improves neurological function in aged rats after embolic stroke. Cell Transplant. 31, 31. doi:10.3727/096368912X658674
169. Zhang, R., Wang, Y., Zhang, L., Zhang, Z., Tsang, W., Lu, M., et al. (2002). Sildenafil (Viagra) induces neurogenesis and promotes functional recovery after stroke in rats. Stroke 33, 2675-2680. doi:10.1161/01.STR.0000034399.95249.59
170. Zhang, R., Zhang, L., Zhang, Z., Wang, Y., Lu, M., Lapointe, M., et al. (2001). A nitric oxide donor induces neurogenesis and reduces functional deficits after stroke in rats. Ann. Neurol. 50, 602-611. doi:10.1002/ana.1249
171. Zhang, R. L., Zhang, Z. G., Lu, M., Wang, Y., Yang, J. J., and Chopp, M. (2006). Reduction of the cell cycle length by decreasing G1 phase and cell cycle reentry expand neuronal progenitor cells in the subventricular zone of adult rat after stroke. J. Cereb. Blood Flow Metab. 26, 857-863. doi:10.1038/sj.jcbfm. 9600237
172. Zhang, R. L., Zhang, Z. G., Roberts, C., LeTourneau, Y., Lu, M., Zhang, L., et al. (2008). Lengthening the G(1) phase of neural progenitor cells is concurrent with an increase of symmetric neuron generating division after stroke. J. Cereb. Blood Flow Metab. 28, 602-611. doi:10.1038/sj.jcbfm.9600556
173. Zhang, Z. G., and Chopp, M. (2009). Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurol. 8, 491-500. doi:10.1016/S1474-4422(09)70061-4
174. Zhao, L.-R., Duan, W.-M., Reyes, M., Keene, C. D., Verfaillie, C. M., and Low, W. C. (2002). Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp. Neurol. 174, 11-20. doi:10.1006/exnr.2001.7853
175. Zhu, C. J., Dong, J. X., Li, J., Zhang, M. J., Wang, L. P., and Luo, L. (2011). Preliminary study on the mechanism of acupoint injection of bone marrow mesenchymal stem cells in improving blood flow in the rat of hind limb ischemia. J. Tradit. Chin. Med. 31, 241-245.